BamSEC and AlphaSense Join Forces
Learn More

Galera Therapeutics Inc.

OTC: GRTX    
Share price (1/8/25): $0.05    
Market cap (1/8/25): $2.529 million

Material Contracts Filter

EX-10.2
from 8-K 26 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 8 pages August 28, 2024 Chris Degnan Re: Separation Agreement Dear Chris: This Letter Sets Forth the Terms of the Separation Agreement (This “Agreement”) That Galera Therapeutics, Inc. (The “Company”) Is Offering to You to Aid in Your Employment Transition From the Company
12/34/56
EX-10.1
from 10-Q 10 pages June 4, 2024 Robert A. Beardsley, PH.D. Re: Separation Agreement 1
12/34/56
EX-10.1
from 10-Q 7 pages Separation Agreement and General Release
12/34/56
EX-10
from 10-Q 48 pages Securities Purchase Agreement
12/34/56
EX-10
from 10-Q 32 pages Galera Therapeutics, Inc. 2023 Employment Inducement Award Plan
12/34/56
EX-10
from 10-Q 6 pages Galera Therapeutics, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.2
from 8-K 35 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 25 pages Galera Therapeutics, Inc. Placement Agency Agreement
12/34/56
EX-10.2
from 10-Q 26 pages Galera Therapeutics, Inc. Employment, Confidentiality, Noncompete and Invention Rights Agreement
12/34/56
EX-10.1
from 10-Q 32 pages Galera Therapeutics, Inc. Employment, Confidentiality, Noncompete and Invention Rights Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Galera Therapeutics, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.6
from 10-K 29 pages Galera Therapeutics, Inc. Employment, Confidentiality, Noncompete and Invention Rights Agreement
12/34/56
EX-10.3
from 10-Q 26 pages Galera Therapeutics, Inc. Employment, Confidentiality, Noncompete and Invention Rights Agreement
12/34/56
EX-10.2
from 10-Q 26 pages Galera Therapeutics, Inc. Employment, Confidentiality, Noncompete and Invention Rights Agreement
12/34/56
EX-10.0
from 8-K 49 pages Master Manufacturing Services Agreement Effective Date: August 13, 2021
12/34/56
EX-10.10
from 10-K 4 pages Galera Therapeutics, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.2
from 10-Q 18 pages Warrant Purchase Agreement
12/34/56
EX-10.1
from 10-Q 11 pages Galera Therapeutics Inc. Amendment No. 1 to Amended and Restated Purchase and Sale Agreement
12/34/56